scispace - formally typeset
T

Tania F. Gendron

Researcher at Mayo Clinic

Publications -  119
Citations -  12409

Tania F. Gendron is an academic researcher from Mayo Clinic. The author has contributed to research in topics: C9orf72 & Trinucleotide repeat expansion. The author has an hindex of 52, co-authored 100 publications receiving 9947 citations.

Papers
More filters
Journal ArticleDOI

Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS

TL;DR: The specificity of C9RANT for c9FTD/ALS is a potential biomarker for this most common cause of FTD and ALS and have significant implications for treatment strategies directed at RAN-translated peptides and their aggregation and the RNA structures necessary for their production.
Journal ArticleDOI

Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS

TL;DR: In this paper, the authors examined whether antisense transcripts resulting from bidirectional transcription of the expanded GGGGCC repeat behave in a similar manner and showed that ectopic expression of (CCCCGG)66 in cultured cells results in foci formation.
Journal ArticleDOI

Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice

TL;DR: Transgenic mice expressing full-length human TDP-43 (hTDP- 43) driven by the mouse prion promoter are generated to provide a tool to analyze the role of wild-type hT DP-43 in the brain and spinal cord and for studying TDP -43-associated neurotoxicity.